$THRM News

JP Morgan Maintains Neutral on Gentherm, Raises Price Target to $48

Stifel Maintains Buy on Gentherm, Raises Price Target to $59

Gentherm Incorporated 2026 Q2 - Results - Earnings Call Presentation

Gentherm (NASDAQ: THRM) Surges on Q2 Beat, Raised Guidance, and $400M Buyback as a Quality Growth Stock

Gentherm Incorporated (THRM) Q2 2026 Earnings Call Transcript

Gentherm Q2 2026 Earnings Call Transcript

Gentherm Board Approves New $400M Stock Buyback Program

Gentherm Raises FY2026 Sales Guidance from $1.500B-$1.600B to $1.550B-$1.650B vs $1.560B Est

Gentherm Acquires Innovative Medical Equipment; Financial Terms Undisclosed

Gentherm Receives FDA 510(k) Clearance For Its Patented ThermAffyx Patient Safety System

Stifel Maintains Buy on Gentherm, Raises Price Target to $44

Gentherm Incorporated (THRM) Presents at 2026 Baird Global Consumer, Technology & Services Conference - Slideshow

Gentherm Offers Too Much Upside To Be Underperforming Like This

JP Morgan Maintains Neutral on Gentherm, Raises Price Target to $38

Gentherm Incorporated 2026 Q1 - Results - Earnings Call Presentation

Stifel Maintains Buy on Gentherm, Raises Price Target to $38

Baird Maintains Neutral on Gentherm, Raises Price Target to $34

Gentherm Incorporated (THRM) Q1 2026 Earnings Call Transcript

**Gentherm (NASDAQ:THRM) Shares Surge After Crushing Q1 Estimates with Record Revenue and EPS Beat**

Gentherm shares are trading higher after the company reported better-than-expected Q1 financial results.